Ocular Surgery News APAO Edition Current Issue

The following articles appeared in the print edition of Ocular Surgery News APAO Edition.

Table of Contents

• Retina specialists explore anti-VEGF treatments for diabetic eye disease
• Some challenges remain in the management of DME Dennis S.C. Lam, MD, FRCOphth; Mårten Brelén, BMBCh, FRCOphth, PhD
• BLOG: Gluing the IOL beneath the cataract
• Call for APAO International Fellowship Program applications
• Laser intrastromal astigmatic keratotomy yields stable correction up to 6 months
• Zeiss reports revenue increase in first 9 months of fiscal year
• Options exist for IOL insertion in presence of compromised capsular bag Uday Devgan, MD
• Glued IOL scaffold can be used to manage Soemmering’s ring Amar Agarwal, MS, FRCS, FRCOphth; Priya Narang, MS
• Application of whole blood before staining improves outcomes of macular hole surgery
• ILM peeling, gas tamponade correlated with dissociated optic nerve fiber layer
• Risks identified for early corneal haze after myopic PRK
• SMILE for myopia has little effect on simulated night vision, contrast sensitivity
• Anti-VEGF injection frequency a key factor in visual outcomes
• ATLAS study: Treat-and-extend with aflibercept reduces AMD treatment burden
• Device inadequacy seen as factor in failure of encapsulated cell therapy to meet goal
• High genetic risk for AMD may predict benefit from antioxidants
• Novel bispecific monoclonal antibody explored for treating wet AMD
• ORBIT study: Efficacy of ocriplasmin in resolving VMA linked to baseline features
• Ranibizumab improves diabetic retinopathy severity score
• Single-session short-duration pattern-scanning laser PRP may be appropriate for advanced diabetic retinopathy
• Sirolimus reduces central subfield thickness in eyes with persistent subretinal fluid
• Steroid implant reduces macular thickness with small vision gain
• Study: Ocriplasmin achieves better VMT release rates than in MIVI-TRUST, but concerns remain
• Surgeon: Advantages of bilateral sequential vitrectomy outweigh disadvantages in stage 4 or 5 ROP
• Survey reveals global trends and differences among retina specialists
• Sustained low-dose steroid slows progression of diabetic retinopathy
• Topical squalamine under study for treatment of occult lesions
• TREX-AMD study shows relationship of risk factors to macular atrophy
• VIDEO: Bausch + Lomb introduces new retina team, instruments
• VIDEO: Cataract surgery safe in patients undergoing aflibercept therapy for DME
• VIDEO: Novel molecule in development for treatment of wet AMD
• VIDEO: Review finds no difference in anti-VEGF agents used for diabetic retinopathy
• VIDEO: Speaker discusses key findings from RISE and RIDE trials
• VIDEO: Specialist reviews results of DRCR.net Protocol S
• Visual outcomes poor after therapeutic pars plana vitrectomy in patients with endophthalmitis
• West African Ebola survivors at higher risk for blindness, vision complications
• High-frequency deep sclerotomy another option for surgical treatment of glaucoma D.J. Vukosavljevic, MD; Miroslav Vukosavljevic, MD; B. Pajic, MD, PhD; M. Kontic